Cargando…
Chemically-Modified Curcumin 2.24: A Novel Systemic Therapy for Natural Periodontitis in Dogs
PURPOSE: To determine the effect of a pleiotropic MMP-inhibitor, a novel chemically-modified curcumin 2.24 (CMC2.24), on the clinical and biological measures of naturally-occurring periodontitis in the beagle dog. METHODS: Eight adult female dogs with generalized periodontitis were distributed into...
Autores principales: | Deng, Jie, Golub, Lorne M, Lee, Hsi-Ming, Lin, Michael C, Bhatt, Heta Dinesh, Hong, Hou-Lin, Johnson, Francis, Scaduto, Joseph, Zimmerman, Thomas, Gu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020920/ https://www.ncbi.nlm.nih.gov/pubmed/32104105 http://dx.doi.org/10.2147/JEP.S236792 |
Ejemplares similares
-
A novel modified-curcumin 2.24 resolves inflammation by promoting M2 macrophage polarization
por: Deng, Jie, et al.
Publicado: (2023) -
Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications
por: Wang, Howard H, et al.
Publicado: (2019) -
The Maximum-Tolerated Dose and Pharmacokinetics of a Novel Chemically Modified Curcumin in Rats
por: Bhatt, Heta Dinesh, et al.
Publicado: (2022) -
Efficacy of a Novel Pleiotropic MMP-Inhibitor, CMC2.24, in a Long-Term Diabetes Rat Model with Severe Hyperglycemia-Induced Oral Bone Loss
por: Bhatt, Heta Dinesh, et al.
Publicado: (2023) -
A Novel Chemically Modified Curcumin Reduces Severity of Experimental Periodontal Disease in Rats: Initial Observations
por: Elburki, Muna S., et al.
Publicado: (2014)